OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Research is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases	1678
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome	241
Macrophage polarization and diabetic wound healing	203
TMAO: how gut microbiota contributes to heart failure	112
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact	96
Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model	89
miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer	86
Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients	85
Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort	73
New and alternative strategies for the prevention, control, and treatment of antibiotic-resistant Campylobacter	71
Immune responses to injury and their links to eye disease	69
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?	67
Oral wound healing models and emerging regenerative therapies	64
COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease	64
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies	63
The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet	60
Pathogenesis of heparin-induced thrombocytopenia	60
Microvascular thrombosis: experimental and clinical implications	59
Frailty and cognitive decline	55
Frailty and aging in cancer survivors	51
Topical application of bacteriophages for treatment of wound infections	48
Mechanisms and biomarkers of cancer-associated thrombosis	48
Cutaneous innervation in impaired diabetic wound healing	46
Antiphospholipid syndrome	45
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?	43

Targeting T-type/CaV3.2 channels for chronic pain	43
Next-generation direct-acting influenza therapeutics	42
Diabetic wound healing in soft and hard oral tissues	41
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials	40
Pre-eclampsia predictive ability of maternal miR-125b: a clinical and experimental study	39
Long and short non-coding RNA and radiation response: a review	35
Cellular senescence in age-related disorders	34
Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease	34
Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome	33